BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2018
View Archived Issues
Disconnecting bone building from resorption may be osteoporosis strategy
Read More
Myocardial regeneration outcomes using WJMSCs presented from pilot cohort of CIRCULATE-AMI study
Read More
Identification of a mosquito salivary gland protein that partially limits malaria transmission
Read More
MPO-0112 ameliorates scopolamine-induced cognitive impairment in mice
Read More
Ozalin becomes the first oral pediatric sedative to receive marketing authorization in Europe
Read More
BioArctic enters research collaboration with Brain Biomarker Solutions in Alzheimer's
Read More
New sphingolipid-biased phenotypic approach for the discovery of new targets and new leads
Read More
XBiotech presents positive interim data for initial cohort of bermekimab pilot study
Read More
FDA approves subcutaneous Actemra for active systemic juvenile idiopathic arthritis
Read More
Bone Therapeutics reports final data from phase I/IIa study of ALLOB in delayed-union fractures
Read More
Merck & Co. evaluating MK-1654 in phase I/II study in healthy preterm and full-term infants
Read More
FDA approves Lumoxiti for relapsed or refractory hairy cell leukemia
Read More
Patient recruitment ongoing in phase I study of INCAGN-02390
Read More
TD-1473 being evaluated in phase II study in patients with active Crohn's disease
Read More
Natera enters agreement with Bristol-Myers Squibb for use of Signatera ctDNA assay in Opdivo trial
Read More
Biogen begins clinical evaluation of BIIB-078 in C9ORF72-associated ALS
Read More
Arrowhead Pharmaceuticals patents RNAi for thromboembolic disorders
Read More
GSK begins first-in-human study of GSK-3439171A
Read More
Hanyang University presents new MAPK 10 inhibitors
Read More
Merck & Co. synthesizes new IDO1 inhibitors
Read More
Monash University and GSK present discovery of novel compound for treatment of Chagas disease
Read More
NTZ-2020 and NTZ-2027 as promising new candidates for the treatment and diagnosis of CNS disease
Read More